P W Johnson Selected Research

P W Johnson Research Topics

6	Neoplasms (Cancer) 01/2017 - 01/2000
3	Infections 06/2007 - 01/2000
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2000 - 02/2000
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 01/2000
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2000 - 04/2000
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2000 - 01/2000
1	Cytokine Release Syndrome 03/2014
1	Lymphoma (Lymphomas) 12/2012
1	Fatigue 10/2009
1	Cryptosporidiosis 07/2001
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2001
1	Neutropenia 01/2001
1	Thrombocytopenia (Thrombopenia) 01/2001
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2001
1	Multiple Myeloma 04/2000
1	Ovarian Neoplasms (Ovarian Cancer) 04/2000
1	Hodgkin Disease (Hodgkin's Disease) 04/2000
1	Splenomegaly 01/2000
1	Disease Progression 01/2000

3	Rituximab (Mabthera)FDA Link 04/2000 - 01/2000
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2000 - 04/2000
2	Monoclonal AntibodiesIBA 04/2000 - 01/2000
2	fludarabine phosphate (Fludara)FDA LinkGeneric 04/2000 - 01/2000
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	LigandsIBA 03/2014
1	CytokinesIBA 03/2014
1	Interleukin-6 (Interleukin 6)IBA 03/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2014
1	LipopolysaccharidesIBA 03/2014
1	Indicators and Reagents (Reagents)IBA 10/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2007
1	ChlorineIBA 07/2001
1	Drinking WaterIBA 07/2001
1	AntibodiesIBA 06/2001
1	Therapeutic UsesIBA 06/2001
1	Alkaline PhosphataseIBA 01/2001
1	Amifostine (Ethyol)FDA LinkGeneric 01/2001
1	Etoposide (VP 16)FDA LinkGeneric 01/2001
1	Ifosfamide FDA LinkGeneric 01/2001
1	SodiumIBA 01/2001
1	Carboplatin (JM8)FDA LinkGeneric 01/2001
1	Proteins (Proteins, Gene)FDA Link 11/2000
1	fludarabineIBA 07/2000
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2000
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2000
1	Cisplatin (Platino)FDA LinkGeneric 04/2000
1	Alkylating AgentsIBA 01/2000
1	thiamine triphosphorate (TTP)IBA 01/2000